Human CD25/IL-2 R alpha Quantikine SixPak (6 Plates)

• Supplier: R&D Systems
• Catalog: SR2A00
• Category: ELISA Kit
• Assay Type: Solid Phase Sandwich ELISA
• Sample Type: Cell Culture Supernates (10 µL), Serum (13 µL), EDTA Plasma (13 µL), Heparin Plasma (13 µL)
• Sensitivity: 10 pg/mL
• Range: 78 - 5,000 pg/mL (Serum, Heparin Plasma, Cell Culture Supernates, EDTA Plasma)
• Format: 96-well strip plate
• Description: The Quantikine Human IL-2 sR alpha Immunoassay is a 3.5 hour solid phase ELISA designed to measure IL-2 sR alpha in cell culture supernates, serum, and plasma
• Gene: IL2RA

Product References

Malignant transformation of CD4+ T lymphocytes mediated by oncogenic kinase - Malignant transformation of CD4+ T lymphocytes mediated by oncogenic kinase

Marzec M, Halasa K, Liu X, Wang HY, Cheng M, Baldwin D, Tobias JW, Schuster SJ, Woetmann A, Zhang Q, Turner SD, Odum N, Wasik MA. J Immunol. 2013 Dec 15;191(12):6200-7.

Elevated levels of CXCL10 in the Periodic Fever, Aphthous stomatitis, Pharyngitis - Elevated levels of CXCL10 in the Periodic Fever, Aphthous stomatitis, Pharyngitis

Forsvoll J, Kristoffersen EK, Oymar K. Pediatr Rheumatol Online J. 2013 Oct 17;11(1):38.

Synergistic antitumor activity of anti-CD25 recombinant immunotoxin LMB-2 with - Synergistic antitumor activity of anti-CD25 recombinant immunotoxin LMB-2 with

Singh R, Zhang Y, Pastan I, Kreitman RJ. Clin Cancer Res. 2012 Jan 1;18(1):152-60.

Human CD1c (BDCA-1)+ myeloid dendritic cells secrete IL-10 and display an - Human CD1c (BDCA-1)+ myeloid dendritic cells secrete IL-10 and display an

Kassianos AJ, Hardy MY, Ju X, Vijayan D, Ding Y, Vulink AJ, McDonald KJ, Jongbloed SL, Wadley RB, Wells C, Hart DN, Radford KJ. Eur J Immunol. 2012 Jun;42(6):1512-22.

A novel role for IL-22R1 as a driver of inflammation. - A novel role for IL-22R1 as a driver of inflammation.

Savan R, McFarland AP, Reynolds DA, Feigenbaum L, Ramakrishnan K, Karwan M, Shirota H, Klinman DM, Dunleavy K, Pittaluga S, Anderson SK, Donnelly RP, Wilson WH, Young HA. Blood. 2011 Jan 13;117(2):575-84.

Phase 2 study of cladribine followed by rituximab in patients with hairy cell - Phase 2 study of cladribine followed by rituximab in patients with hairy cell

Ravandi F, O'Brien S, Jorgensen J, Pierce S, Faderl S, Ferrajoli A, Koller C, Challagundla P, York S, Brandt M, Luthra R, Burger J, Thomas D, Keating M, Kantarjian H. Blood. 2011 Oct 6;118(14):3818-23.

Defucosylated humanized anti-CCR4 monoclonal antibody KW-0761 as a novel - Defucosylated humanized anti-CCR4 monoclonal antibody KW-0761 as a novel

Ishii T, Ishida T, Utsunomiya A, Inagaki A, Yano H, Komatsu H, Iida S, Imada K, Uchiyama T, Akinaga S, Shitara K, Ueda R. Clin Cancer Res. 2010 Mar 1;16(5):1520-31.

Presence of IL-5 protein and IgE antibodies to staphylococcal enterotoxins in - Presence of IL-5 protein and IgE antibodies to staphylococcal enterotoxins in

Bachert C, Zhang N, Holtappels G, De Lobel L, van Cauwenberge P, Liu S, Lin P, Bousquet J, Van Steen K. J Allergy Clin Immunol. 2010 Nov;126(5):962-8, 968.e1-6. doi:

Safety and clinical effect of subcutaneous human interleukin-21 in patients with - Safety and clinical effect of subcutaneous human interleukin-21 in patients with

Schmidt H, Brown J, Mouritzen U, Selby P, Fode K, Svane IM, Cook GP, Mollerup DH, Geertsen PF. Clin Cancer Res. 2010 Nov 1;16(21):5312-9.

Effective treatment of a murine model of adult T-cell leukemia using depsipeptide - Effective treatment of a murine model of adult T-cell leukemia using depsipeptide

Chen J, Zhang M, Ju W, Waldmann TA. Blood. 2009 Feb 5;113(6):1287-93.